Keywords: کورتیکواستروئید خوراکی; Severe asthma; Exacerbations; Decline in lung function; FEV1; COPD; Chronic obstructive pulmonary disease; FVC; Forced vital capacity; OCS; Oral corticosteroid;
مقالات ISI کورتیکواستروئید خوراکی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کورتیکواستروئید خوراکی; Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
Keywords: کورتیکواستروئید خوراکی; Urticaria; Biomarkers; CRP; IL-6; MPV; D-dimer; F1+2; Biologics; Omalizumab; ASCENT-I; ASCENT-II; GLACIAL; IL-1 antagonists; TNF-α inhibitors; Intravenous immunoglobulin; Rituximab; Ligelizumab; Quilizumab; ASST; Autologous serum skin test; ATA; Antithyr
Keywords: کورتیکواستروئید خوراکی; Asthma control; Children; Asthma; Health resource utilization; Expenditures; AC; All-cause; ACQ; Asthma Control Questionnaire; AS; Asthma-specific; ED; Emergency department; HC; Household Component; HRU; Health resource utilization; ICD-9; International C
Keywords: کورتیکواستروئید خوراکی; Severe asthma; eosinophilia; autoantibodies; sputum; eosinophil degranulation; eosinophil peroxidase; autoimmunity; anti-nuclear antibodies; Abs600; Absorbance at 600Â nm; ANA; Anti-nuclear antibody; BAFF; B cell-activating factor of the TNF family; BCA
Keywords: کورتیکواستروئید خوراکی; Oral corticosteroids; adverse effects; severe asthma; burst therapy; AE; Adverse effect; ICD-9; International Classification of Diseases, Ninth Edition; ICS; Inhaled corticosteroid; NCC; Number of chronic conditions (excluding asthma); OCS; Oral corticost
Keywords: کورتیکواستروئید خوراکی; Asthma; quality of life; measurement/standardized measures; clinical outcomes; patient-centered outcomes; ACT; Asthma Control Test; A-IQOLS; Asthma Impact on Quality of Life Scale; AOW; Asthma Outcomes Workshop; ASUI; Asthma Symptom Utility Index; CR; Coe
Keywords: کورتیکواستروئید خوراکی; Nonpharmacologic therapy; Bronchial thermoplasty; Pulmonary rehabilitation; Breathing techniques; AIR; Asthma Intervention Research; BT; Bronchial thermoplasty; BBT; Buteyko breathing technique; COPD; Chronic obstructive pulmonary disease; ED; Emergency d
Keywords: کورتیکواستروئید خوراکی; Asthma; Pregnancy; Exacerbation; Macrophage; CD163; Inflammation; Eosinophil; Exhaled nitric oxide; BMI; Body mass index; CRP; C-reactive protein; Feno; Fractional exhaled nitric oxide; GWG; Gestational weight gain; ICS; Inhaled corticosteroid; OCS; Oral
Keywords: کورتیکواستروئید خوراکی; Allergy; atopy; bronchiolitis; child; eczema; rhinovirus; respiratory syncytial virus; sensitization; virus; wheeze; wheezing; API; Asthma Predictive Index; ICS; Inhaled corticosteroid; OCS; Oral corticosteroid; OR; Odds ratio; RSV; Respiratory syncytial
Keywords: کورتیکواستروئید خوراکی; asthma; Medicaid; readmission; ED; Emergency department; ICS; Inhaled corticosteroids; OCS; Oral corticosteroid;
Keywords: کورتیکواستروئید خوراکی; Mepolizumab; Omalizumab; Severe asthma; Exacerbations; Lung function; Tolerability; Crl; credible interval; HRQoL; health related quality of life; ITC; indirect treatment comparison; MEPO; mepolizumab; OCS; oral corticosteroid; OMA; omalizumab; RCT; rando
Keywords: کورتیکواستروئید خوراکی; Asthma Control Test; Asthma; Short-acting beta-agonist; Bronchodilator agents; Asthma exacerbation; Asthma rescue medication; ACT; Asthma Control Test; AUC; Area under the curve; ICS; Inhaled corticosteroid; MDI; Metered-dose inhaler; NPV; Negative predic
Keywords: کورتیکواستروئید خوراکی; Eosinophils; biomarkers; severe eosinophilic asthma; DREAM; Dose Ranging Efficacy and safety With Mepolizumab in Severe Asthma; Feno; Fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; Inhaled corticosteroid; MENSA; Mepolizumab Adj
Keywords: کورتیکواستروئید خوراکی; Antiasthmatic agents; exacerbation; emergency service; hospital; IL-5; mepolizumab; severe eosinophilic asthma; meta-analysis; IV; Intravenous; OCS; Oral corticosteroid; SC; Subcutaneous;
Keywords: کورتیکواستروئید خوراکی; Omalizumab; Allergic asthma; IgE; Meta-analysis; Effectiveness; ACT; Asthma Control Test; AQLQ; Asthma-related Quality-of-Life Questionnaire; FEV1; Forced expiratory volume in 1 second; GETE; Global Evaluation of Treatment Effectiveness scale; ICS; Inhale
Keywords: کورتیکواستروئید خوراکی; Allergy; asthma; IgE; omalizumab; pediatric; AA; Allergic asthma; AE; Adverse event; EMA; European Medicines Agency; EXCELS; Epidemiologic Study of Xolair (omalizumab): Evaluating Clinical Effectiveness and Long-term Safety in Patients with Moderate-to-Se
Keywords: کورتیکواستروئید خوراکی; Severe asthma; Biologic therapy; Pharmacoeconomics; Health care resource use; Oral corticosteroid; Personalized medicine;
Keywords: کورتیکواستروئید خوراکی; Asthma; Attack; Control; Medical record; Observational; Risk factor; ICS; Inhaled corticosteroid; LABA; Long-acting β2 agonist; OCS; Oral corticosteroid; OPCRD; Optimum Patient Care Research Database;
Keywords: کورتیکواستروئید خوراکی; Administrative data; Corticosteroid; Comorbidities; Allergist; Asthma specialist; Asthma control; Blood eosinophil count; Chronic oral corticosteroid use; Controller medication; Exacerbations; Asthma guidelines; Managed care; Persistent asthma; Short-acti
Keywords: کورتیکواستروئید خوراکی; Refractory asthma; asthma control; airway smooth muscle; airway remodeling; epithelium neuroendocrine cells; mucosal nerves; bronchial epithelium; ACT; Asthma Control Test; AQLQ; Asthma Quality of Life Questionnaire; ASM; Airway smooth muscle; BT; Bronchi
Keywords: کورتیکواستروئید خوراکی; Asthma; small airways; acinus; physiology; ACQ; Asthma Control Questionnaire; ADC; Apparent diffusion coefficient; CDI; Convection-dependent inhomogeneity; CT; Computed tomography; DCDI; Diffusion-convection-dependent inhomogeneity; FRC; Functional resi
Keywords: کورتیکواستروئید خوراکی; Asthma; asthma severity; fibrocytes; peripheral blood; biomarker; APC; Allophycocyanin; ATS; American Thoracic Society; Col1; Collagen 1; EGFR; Epithelial growth factor receptor; FACS; Fluorescence-activated cell sorting; FVC; Forced vital capacity; GINA;
Keywords: کورتیکواستروئید خوراکی; Asthma; microbiome; corticosteroids; FEV1; bacteria; 16S ribosomal RNA; BAL; Bronchoalveolar lavage; EB; Endobronchial brushing; FDR; False discovery rate; GLM; Generalized linear regression model; ICS; Inhaled corticosteroid; OCS; Oral corticosteroid; OT
Keywords: کورتیکواستروئید خوراکی; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; GERD; gastroesophageal reflux disease; OC; oral corticosteroid; QoL; quality of life;
Keywords: کورتیکواستروئید خوراکی; aOR; adjusted OR; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; OCS; oral corticosteroid; PEF; peak expiratory flow;
Keywords: کورتیکواستروئید خوراکی; Asthma; asthma control; asthma exacerbations; dupilumab; biomarkers; inhaled corticosteroids; lebrikizumab; long-acting Ã-adrenergic agonists; mepolizumab; omalizumab; reslizumab; severe asthma; therapeutics; ACQ; Asthma control questionnaire; BADGER; Be
Keywords: کورتیکواستروئید خوراکی; Asthma phenotypes; biologic therapies; eosinophils; IgE; IL-4; IL-5; IL-13; TH2/type 2 inflammation; ACQ; Asthma Control Questionnaire; DBPC; Double-blind, placebo-controlled; FDA; US Food and Drug Administration; Feno; Fraction of exhaled nitric oxide; I
Keywords: کورتیکواستروئید خوراکی; Asthma; bone mineral density; child; corticosteroids; APPL1; Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1; BMA; Bone mineral accretion; BMD; Bone mineral density; CAMP; Childhood Asthma Management Program; eQTL;
Keywords: کورتیکواستروئید خوراکی; Clusters; outcomes; prospective study; exacerbation; ACQ-6; 6-Item Asthma Control Questionnaire; ICS; Inhaled corticosteroid; LABA; Long-acting β2-agonist; OCS; Oral corticosteroid; SARP; Severe Asthma Research Program;
Keywords: کورتیکواستروئید خوراکی; Allergic asthma; Anti-IgE; Exacerbations; Omalizumab; ATE; Arterial thromboembolic event; ED; Emergency department; EXCELS; The Epidemiologic Study of Xolair (omalizumab); FDA; US Food and Drug Administration; FeNO; Fraction of exhaled nitric oxide; GETE;
Keywords: کورتیکواستروئید خوراکی; Asthma; Comparative effectiveness; Retrospective cohort study; Inhaled corticosteroids; Long-acting β2-adrenergic agonist; short-acting β2-adrenergic-agonists; Budesonide-formoterol combination; Fluticasone-salmeterol combination; BFC; Budesonide-form
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma
Keywords: کورتیکواستروئید خوراکی; Asthma; Biologic; Eosinophil; Exacerbation; Interleukin-5 receptor; CI; confidence interval; FEV1; forced expiratory volume in 1 s; ICS; inhaled corticosteroid; IL-5; interleukin-5; LABA; long-acting β2-agonist; OCS; oral corticosteroid; Q4W; every 4 we
Should a Preschool Child with Acute Episodic Wheeze be Treated with Oral Corticosteroids? AÂ Pro/Con Debate
Keywords: کورتیکواستروئید خوراکی; AIMS; Acute Intervention Management Strategies; API; Asthma predictability index; ED; Emergency department; ICS; Inhaled corticosteroid; mAPI; Modified asthma predictability index; MIST; Maintenance and Intermittent Inhaled Corticosteroids in Wheezing Tod
Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control
Keywords: کورتیکواستروئید خوراکی; Omalizumab; Discontinuation; Asthma control; Duration of treatment; GINA; global initiative for asthma; IgE; immunoglobulin E; FcεRI; high-affinity IgE receptor; BMI; body mass index; FEV1; forced expiratory volume (1 s); ICS; inhaled corticosteroid; OC
Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR Cohort
Keywords: کورتیکواستروئید خوراکی; Severe or difficult-to-treat asthma; Uncontrolled asthma; Exacerbations; Asthma therapy; Asthma guidelines; Anti-asthmatic agents; BMI; Body mass index; COPD; Chronic obstructive pulmonary disease; ED; Emergency department; EPR-3; Expert Panel Report 3; F
Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: AÂ randomized trial
Keywords: کورتیکواستروئید خوراکی; IL-13; IL13Rα1; IL13Rα2; efficacy; safety; pharmacokinetics; pharmacodynamics; ACQ; Asthma Control Questionnaire; ADA; Anti-drug antibody; AE; Adverse event; ECLIA; Electrochemiluminescence immunoassay; Feno; Fraction of exhaled nitric oxide; FPE; Fluti
Development and Preliminary Validation of the Adult Asthma Adherence QuestionnaireTM
Keywords: کورتیکواستروئید خوراکی; Asthma; Adherence; Questionnaire; Asthma control; Inhaled corticosteroid; AAAQ; Adult Asthma Adherence QuestionnaireTM; ACT; Asthma Control Test; ICS; inhaled corticosteroid; KPSC; Kaiser Permanente Southern California; OCS; oral corticosteroid; PDC; Perc
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma
Keywords: کورتیکواستروئید خوراکی; Bronchial thermoplasty; asthma; bronchoscopic procedure; Alair System; asthma exacerbation; AE; Adverse event; AIR2; Asthma Intervention Research 2; AQLQ; Asthma Quality of Life Questionnaire; BT; Bronchial thermoplasty; ED; Emergency department; HRCT; Hi
Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?
Keywords: کورتیکواستروئید خوراکی; Oral corticosteroids; episodic wheezing; preschool children; AIMS; Acute Management Intervention Strategies; AUC; Area under the curve; ICS; Inhaled corticosteroid; LRTI; Lower respiratory tract illnesses; mAPI; Modified Asthma Predictive Index; MIST; Mai
Endocrine effects of inhaled budesonide compared with inhaled fluticasone propionate and oral prednisolone in healthy Beagle dogs
Keywords: کورتیکواستروئید خوراکی; Adrenal suppression; Inhaled corticosteroids; Dog; Oral corticosteroid; ACTH stimulation test
The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population
Keywords: کورتیکواستروئید خوراکی; Long-acting β-agonist; inhaled corticosteroid; severe asthma exacerbation; safety; racially and ethnically diverse population; observational study; FDA; US Food and Drug Administration; HR; Hazard ratio; ICS; Inhaled corticosteroid; LABA; Long-acting β-
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
Keywords: کورتیکواستروئید خوراکی; TENOR; severe or difficult-to-treat asthma; asthma control; asthma exacerbations; burden; medication; quality of life; allergy; IgE; AD; Atopic dermatitis; AR; Allergic rhinitis; ATAQ; Asthma Therapy Assessment Questionnaire; BMI; Body mass index; ED; Eme
Anti-inflammatory treatment after discharge home from the emergency department in adults with acute asthma
Keywords: کورتیکواستروئید خوراکی; Asthma exacerbation; acute asthma; emergency department; discharge medications; corticosteroids; leukotriene modifiers; ED; Emergency department; ICS; Inhaled corticosteroid; IMCS; Intramuscular corticosteroid; OCS; Oral corticosteroid; RCT; Randomized cl
Impact of Asthma Controller Medications on Clinical, Economic, and Patient-Reported Outcomes
Keywords: کورتیکواستروئید خوراکی; ATAQ; Asthma Therapy Assessment Questionnaire; BMI; body mass index; COPD; chronic obstructive pulmonary disease; ED; emergency department; HIPAA; Health Insurance Portability and Accountability Act; ICD-9-CM; International Classification of Diseases, Nin
Oral Corticosteroid Use for Loss of Flexion After Primary Anterior Cruciate Ligament Reconstruction
Keywords: کورتیکواستروئید خوراکی; Anterior cruciate ligament; Reconstruction; Loss of motion; Oral corticosteroid; Range of motion; KT-1000;
Relationship between Inhaled Corticosteroid Therapy and Rate of Lung Function Decline in Children with Cystic Fibrosis
Keywords: کورتیکواستروئید خوراکی; CF; Cystic fibrosis; ESCF; Epidemiologic Study of Cystic Fibrosis; FEV1; Forced expiratory volume in 1 second; HFA; Height for age; ICS; Inhaled corticosteroid; LABA; Long-acting beta agonist; OCS; Oral corticosteroid;
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study
Keywords: کورتیکواستروئید خوراکی; Asthma; moderate to severe; children; macrolide; leukotriene receptor antagonist; clinical trial; CARE; Childhood Asthma Research and Education; DSMB; Data Safety Monitoring Board; ICS; Inhaled corticosteroid; MARS; Montelukast or Azithromycin for Reducti
Patterns of asthma control: A 3-year analysis of patient claims
Keywords: کورتیکواستروئید خوراکی; Asthma; asthma control; administrative claims; asthma variability; controller medications; ED; Emergency department; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; OCS; Oral corticosteroid; SABA; Short-acting β2-agonist;
Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma
Keywords: کورتیکواستروئید خوراکی; asthma; ciclesonide; cortisol; fluticasone; hypothalamic-pituitary-adrenal axis; ACTH; adrenocorticotrophic hormone; ANCOVA; analysis of covariance; AUC0-24h; area under the curve for 0 to 24 h; CFC; chlorofluorocarbon; CI; confidence interval; CIC; cic